Company Filing History:
Years Active: 2021
Title: Yeasel Jeon: Innovator in Pain Management
Introduction
Yeasel Jeon is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pain management through his innovative research and development.
Latest Patents
Yeasel Jeon holds a patent for a groundbreaking invention titled "SCN9A antisense pain killer." This invention provides peptide nucleic acid derivatives that target the 3' splice site of exon 4 in the human SCN9A pre-mRNA. The peptide nucleic acid derivatives potently induce SCN9A mRNA splice variant(s) that lack the SCN9A exon 4 in cells. This innovation is particularly useful for safely treating pains or conditions involving Na1.7 activity.
Career Highlights
Yeasel Jeon is currently associated with Olipass Corporation, where he continues to advance his research in the field of pain management. His work has garnered attention for its potential to improve therapeutic options for patients suffering from chronic pain.
Collaborations
Some of Yeasel Jeon's coworkers include Shin Chung and Daram Jung, who contribute to the collaborative efforts at Olipass Corporation.
Conclusion
Yeasel Jeon's innovative work in developing the SCN9A antisense pain killer highlights his commitment to advancing medical science and improving patient care. His contributions are paving the way for new treatments in pain management.